However, the evidence to support this pathogenesis mechanism of LPS-activated TLR4 signaling comes largely from experimental NASH, data from carbon tetrachloride (CCl4)-induced liver fibrosis model has not been reported currently. The gene discussed is TLR4; the disease is Hepatic fibrosis.